Role of C5a–C5aR Interaction in Sepsis

C5a–C5aR signaling plays an essential role in innate immunity of neutrophils. However, excessive interaction of C5a–C5aR results in harmful effects in these cells. In sepsis, robust generation of C5a occurs; blockade of either C5a or C5aR greatly improves survival in experimental sepsis following cecal ligation and puncture (CLP). The beneficial effects derived from C5a–C5aR interaction are associated with preservation of neutrophil innate immune functions (chemotaxis, phagocytosis, respiratory burst), attenuation of the inflammatory reaction, amelioration of coagulopathy, alteration in adhesion molecule expression, and modulation of apoptosis. Following CLP, C5aR expression is significantly elevated in organs, perhaps setting the stage for C5a-induced organ dysfunction. In contrast, C5aR content on neutrophils drops significantly at early stages of sepsis and progressively increases at later time points. Re-expression of C5aR on neutrophils during sepsis appears to be associated with the functional recovery of neutrophil innate immune functions. Following CLP, there is a positive correlation between C5aR content on blood neutrophils and survival of individual animals; high levels of C5aR on neutrophils are associated with survival, whereas low levels of C5aR on neutrophils predict mortality. These data suggest that in sepsis C5a–C5aR signaling is excessive, resulting in paralysis of neutrophil function. Interception of either C5a or C5aR dramatically improves survival during experimental sepsis.

[1]  E. Deitch.  ANIMAL MODELS OF SEPSIS AND SHOCK: A REVIEW AND LESSONS LEARNED , 1998, Shock.

[2]  T. Raffin,et al.  Effects of anti-C5a antibodies on the adult respiratory distress syndrome in septic primates. , 1986, The Journal of clinical investigation.

[3]  U. Höpken,et al.  The C5a chemoattractant receptor mediates mucosal defence to infection , 1996, Nature.

[4]  P. Ward,et al.  Role of C5a in Multiorgan Failure During Sepsis1 , 2001, The Journal of Immunology.

[5]  I. Chaudry,et al.  IMMUNE DYSFUNCTION IN MURINE POLYMICROBIAL SEPSIS: MEDIATORS, MACROPHAGES, LYMPHOCYTES AND APOPTOSIS , 1996, Shock.

[6]  J. Paulauskis,et al.  Altered Neutrophil Trafficking During Sepsis1 , 2002, The Journal of Immunology.

[7]  J. Drazen,et al.  Characterization of a receptor for C5a anaphylatoxin on human eosinophils. , 1989, The Journal of biological chemistry.

[8]  John D Lambris,et al.  Expression and Function of C5a Receptor in Mouse Microvascular Endothelial Cells1 , 2002, The Journal of Immunology.

[9]  C. Gerard.  Complement C5a in the sepsis syndrome--too much of a good thing? , 2003, The New England journal of medicine.

[10]  G. Weissmann,et al.  Generation of C5-derived lysosomal enzyme-releasing activity (C5a) by lysates of leukocyte lysosomes. , 1974, Journal of immunology.

[11]  T. Hugli,et al.  Endotoxin-induced shock in the rat. A role for C5a. , 1989, The American journal of pathology.

[12]  M. Oppermann,et al.  Inhibition of interleukin‐6 synthesis in an animal model of septic shock by anti‐C5a monoclonal antibodies , 1996, European journal of immunology.

[13]  L. Moldawer,et al.  Targeted adenovirus-induced expression of IL-10 decreases thymic apoptosis and improves survival in murine sepsis , 2001, Proceedings of the National Academy of Sciences of the United States of America.

[14]  I. Chaudry,et al.  THE INDUCTION OF ACCELERATED THYMIC PROGRAMMED CELL DEATH DURING POLYMICROBIAL SEPSIS: CONTROL BY CORTICOSTEROIDS BUT NOT TUMOR NECROSIS FACTOR , 1995, Shock.

[15]  B. Lucchesi,et al.  The anaphylatoxins C3a and C5a are vasodilators in the canine coronary vasculaturein vitro andin vivo , 1991, Agents and Actions.

[16]  M. Titheradge.  Nitric oxide in septic shock. , 1999, Biochimica et biophysica acta.

[17]  B. Cronstein,et al.  Immunocomplexes stimulate different signalling events to chemoattractants in the neutrophil and regulate L-selectin and beta 2-integrin expression differently. , 1994, The Biochemical journal.

[18]  A. Seely,et al.  Alteration of Chemoattractant Receptor Expression Regulates Human Neutrophil Chemotaxis In Vivo , 2002, Annals of surgery.

[19]  P. Ward,et al.  Protective effects of anti-C5a in sepsis-induced thymocyte apoptosis. , 2000, The Journal of clinical investigation.

[20]  A. Lentsch,et al.  Role of complement in in vitro and in vivo lung inflammatory reactions , 1998, Journal of leukocyte biology.

[21]  I. Chaudry,et al.  IL-4-induced activation of the Stat6 pathway contributes to the suppression of cell-mediated immunity and death in sepsis. , 2000, Surgery.

[22]  P. Gasque,et al.  Regulation by complement C3a and C5a anaphylatoxins of cytokine production in human umbilical vein endothelial cells , 2003, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[23]  I. Chaudry,et al.  Does Fas ligand or endotoxin contribute to thymic apoptosis during polymicrobial sepsis? , 1999, Shock.

[24]  Diane S. Allen-Gipson,et al.  Smoke and C5a induce airway epithelial intercellular adhesion molecule-1 and cell adhesion. , 2003, American journal of respiratory cell and molecular biology.

[25]  F. Boulay,et al.  Internalization and recycling of the C5a anaphylatoxin receptor: evidence that the agonist-mediated internalization is modulated by phosphorylation of the C-terminal domain. , 1997, Journal of cell science.

[26]  R. Hotchkiss,et al.  Caspase inhibitors improve survival in sepsis: a critical role of the lymphocyte , 2000, Nature Immunology.

[27]  John D Lambris,et al.  Increased C5a receptor expression in sepsis. , 2002, The Journal of clinical investigation.

[28]  Z. Pan.  Anaphylatoxins C5a and C3a induce nuclear factor kappaB activation in human peripheral blood monocytes. , 1998, Biochimica et biophysica acta.

[29]  T. Hugli,et al.  C3a and C5a enhance granulocyte adhesion to endothelial and epithelial cell monolayers: epithelial and endothelial priming is required for C3a-induced eosinophil adhesion. , 2000, Immunopharmacology.

[30]  J. M. Cousin,et al.  Opposing effects of glucocorticoids on the rate of apoptosis in neutrophilic and eosinophilic granulocytes. , 1996, Journal of immunology.

[31]  D. Cimino,et al.  Internalization of the human N-formyl peptide and C5a chemoattractant receptors occurs via clathrin-independent mechanisms. , 2001, Biochemistry.

[32]  T. Horiuchi,et al.  C5a Induces Tissue Factor Activity on Endothelial Cells , 1997, Thrombosis and Haemostasis.

[33]  Steven D. Carson,et al.  Consecutive enzyme cascades: complement activation at the cell surface triggers increased tissue factor activity. , 1990, Blood.

[34]  J. Krause,et al.  C5L2, a nonsignaling C5A binding protein. , 2003, Biochemistry.

[35]  H. Perez,et al.  Chemotactic responses of human peripheral blood monocytes to the complement-derived peptides C5a and C5a des Arg. , 1985, Journal of immunology.

[36]  J. V. Sarma,et al.  Complement-Induced Impairment of Innate Immunity During Sepsis1 , 2002, The Journal of Immunology.

[37]  T. Fujita,et al.  LPS-induced platelet response and rapid shock in mice: contribution of O-antigen region of LPS and involvement of the lectin pathway of the complement system. , 2002, Blood.

[38]  T. Raffin,et al.  ANIMAL MODEL OF HUMAN DISEASE Adult Respiratory Distress Syndrome A Live E coli Septic Primate Model , 2007 .

[39]  Y. Fukuoka,et al.  Differential cytokine expression of human retinal pigment epithelial cells in response to stimulation by C5a , 2003, Clinical and experimental immunology.

[40]  B. Drénou,et al.  Early Circulating Lymphocyte Apoptosis in Human Septic Shock Is Associated with Poor Outcome , 2002, Shock.

[41]  C. Hack,et al.  Activation of the complement system in baboons challenged with live Escherichia coli: correlation with mortality and evidence for a biphasic activation pattern , 1993, Infection and immunity.

[42]  W. Parks,et al.  Cellular expression of the C5a anaphylatoxin receptor (C5aR): demonstration of C5aR on nonmyeloid cells of the liver and lung. , 1995, Journal of immunology.

[43]  J. V. D. van der Meer,et al.  Inhibition of C5a-induced inflammation with preserved C5b-9-mediated bactericidal activity in a human whole blood model of meningococcal sepsis. , 2003, Blood.

[44]  M. Oppermann,et al.  Binding of fluorescein-labeled anaphylatoxin C5a to human peripheral blood, spleen, and bone marrow leukocytes. , 1992, Blood.

[45]  J. Köhl,et al.  IL-4 Down-Regulates Anaphylatoxin Receptors in Monocytes and Dendritic Cells and Impairs Anaphylatoxin-Induced Migration In Vivo1 , 2003, The Journal of Immunology.

[46]  J. Paulauskis,et al.  Neutrophil C5a receptor and the outcome in a rat model of sepsis , 2003, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[47]  C. Gerard,et al.  The chemotactic receptor for human C5a anaphylatoxin , 1991, Nature.

[48]  M. Yoshida,et al.  Serum complement levels and severity of sepsis. , 1994, Research communications in chemical pathology and pharmacology.

[49]  John D Lambris,et al.  Essential role of the C5a receptor in E coli-induced oxidative burst and phagocytosis revealed by a novel lepirudin-based human whole blood model of inflammation. , 2002, Blood.

[50]  H. Jacob,et al.  Oxygen radicals mediate endothelial cell damage by complement-stimulated granulocytes. An in vitro model of immune vascular damage. , 1978, The Journal of clinical investigation.

[51]  P. Wołkow.  Involvement and dual effects of nitric oxide in septic shock , 1998, Inflammation Research.

[52]  A. Schmaier,et al.  Anti-c5a ameliorates coagulation/fibrinolytic protein changes in a rat model of sepsis. , 2002, The American journal of pathology.

[53]  J. Marshall,et al.  Dysregulated expression of neutrophil apoptosis in the systemic inflammatory response syndrome. , 1997, Archives of surgery.

[54]  P. Ward,et al.  Expression and Function of the C5a Receptor in Rat Alveolar Epithelial Cells1 , 2002, The Journal of Immunology.

[55]  J. Bender,et al.  Regulation of C5a and formyl peptide receptor expression on human polymorphonuclear leukocytes. , 1990, Journal of immunology.

[56]  R. Horuk.  The interleukin-8-receptor family: from chemokines to malaria. , 1994, Immunology today.

[57]  P. Ward,et al.  Protective effects of C5a blockade in sepsis , 1999, Nature Medicine.

[58]  P. Ward,et al.  C5a-dependent up-regulation in vivo of lung vascular P-selectin. , 1997, Journal of immunology.

[59]  J. Younger,et al.  Generation of C5a by phagocytic cells. , 2002, The American journal of pathology.

[60]  A. D. de Weck,et al.  Interleukin 3-dependent mediator release in basophils triggered by C5a , 1989, The Journal of experimental medicine.

[61]  W. Aird.  The role of the endothelium in severe sepsis and multiple organ dysfunction syndrome. , 2003, Blood.

[62]  O. Götze,et al.  Functions of anaphylatoxin C5a in rat liver: direct and indirect actions on nonparenchymal and parenchymal cells. , 2001, International immunopharmacology.

[63]  F. S. Becker,et al.  Cytokine-induced neutrophil-derived interleukin-8. , 1992, The American journal of pathology.

[64]  T. Hugli,et al.  Demonstration of specific C5a receptor on intact human polymorphonuclear leukocytes. , 1978, Proceedings of the National Academy of Sciences of the United States of America.

[65]  P. Ward,et al.  C5 chemotactic fragment induces leukocyte production of tissue factor activity: a link between complement and coagulation. , 1979, The Journal of clinical investigation.

[66]  O. Götze,et al.  C5a suppresses the production of IL-12 by IFN-gamma-primed and lipopolysaccharide-challenged human monocytes. , 1999, Journal of immunology.

[67]  S. Meddows-Taylor,et al.  Altered expression of CD88 and associated impairment of complement 5a-induced neutrophil responses in human immunodeficiency virus type 1-infected patients with and without pulmonary tuberculosis. , 2001, The Journal of infectious diseases.

[68]  M. Heideman,et al.  Anaphylatoxin formation in sepsis. , 1988, Archives of surgery.

[69]  H. Simon.  Neutrophil apoptosis pathways and their modifications in inflammation , 2003, Immunological reviews.

[70]  N. Riedemann,et al.  The FASEB Journal express article 10.1096/fj.02-0033fje. Published online April 23, 2002. C5a receptor and thymocyte apoptosis in sepsis , 2022 .

[71]  B. Jaber,et al.  C5a delays apoptosis of human neutrophils by a phosphatidylinositol 3-kinase-signaling pathway. , 2002, Kidney international.

[72]  P. Ward,et al.  Regulation by C5a of neutrophil activation during sepsis. , 2003, Immunity.